The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2019 | CLL treatment for the old and young
Chronic lymphocytic leukemia (CLL) treatment is different for the young and old. The treatment approaches are discussed here by Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
